duato that mr. burke and mr. duato we can also increase competition but make it easy for generic drugs to get approved. mr. burner, let's turn to the drug eliquis. list price of the talked about $7100 per year. how many generics of this drug could patient in the united states get at the pharmacy today? >> senator, and u.s. that are not yet generics available. >> right. there are zero generic versions of eliquis of able to patients even though the original patterns on the medication began to sunset in 2019. because your company has sued to block two approved generics from the u.s. market until 2028 at the earliest. isn't that right? >> senator, we have allowed for generic entry in 2028, that's correct. >> right. so we're too two generics ready to go. your original patent is well past, expired, but you still are actively trying to prevent generics from coming to market. mr. duato, the list price of johnson & johnson autoimmune arthritis medication stelara is nearly $80,000 annually. similar to other quests that are